110 related articles for article (PubMed ID: 7535040)
21. Hemostasis in patients undergoing extracorporeal circulation: the effect of aprotinin (Trasylol).
Lu H; Soria C; Commin PL; Soria J; Piwnica A; Schumann F; Regnier O; Legrand Y; Caen JP
Thromb Haemost; 1991 Dec; 66(6):633-7. PubMed ID: 1724577
[TBL] [Abstract][Full Text] [Related]
22. Effects of half-dose aprotinin in off-pump coronary artery bypass grafting.
Wei M; Jian K; Guo Z; Li P; Han J; Cai Z; Tarkka M
World J Surg; 2006 Jun; 30(6):1108-14. PubMed ID: 16736344
[TBL] [Abstract][Full Text] [Related]
23. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
Hayashida N; Isomura T; Sato T; Maruyama H; Kosuga K; Aoyagi S
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
[TBL] [Abstract][Full Text] [Related]
24. Effects of aprotinin during cardiopulmonary bypass in patients treated with acetylsalicylic acid.
Ivert T; Intonti M; Stain-Malmgren R; Dumitrescu A; Blombäck M
Scand Cardiovasc J; 1998; 32(5):289-95. PubMed ID: 9835004
[TBL] [Abstract][Full Text] [Related]
25. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
26. The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operations. A scanning electron microscope study of platelet aggregation on extracellular matrix.
Lavee J; Martinowitz U; Mohr R; Goor DA; Golan M; Langsam J; Malik Z; Savion N
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):204-12. PubMed ID: 2915556
[TBL] [Abstract][Full Text] [Related]
27. Aprotinin in pediatric cardiac operations: platelet function, blood loss, and use of homologous blood.
Boldt J; Knothe C; Zickmann B; Wege N; Dapper F; Hempelmann G
Ann Thorac Surg; 1993 Jun; 55(6):1460-6. PubMed ID: 7685588
[TBL] [Abstract][Full Text] [Related]
28. Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss. Results of a double-blind randomized clinical trial.
Kallis P; Tooze JA; Talbot S; Cowans D; Bevan DH; Treasure T
Eur J Cardiothorac Surg; 1994; 8(6):315-22; discussion 22-3. PubMed ID: 7522018
[TBL] [Abstract][Full Text] [Related]
29. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
van der Linden J; Lindvall G; Sartipy U
Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
[TBL] [Abstract][Full Text] [Related]
30. Quality of harvested autologous platelets compared with stored donor platelets for use after cardiopulmonary bypass procedures.
Crowther M; Ford I; Jeffrey RR; Urbaniak SJ; Greaves M
Br J Haematol; 2000 Oct; 111(1):175-81. PubMed ID: 11091198
[TBL] [Abstract][Full Text] [Related]
31. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
[TBL] [Abstract][Full Text] [Related]
32. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
33. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
34. The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations.
Mohr R; Martinowitz U; Lavee J; Amroch D; Ramot B; Goor DA
J Thorac Cardiovasc Surg; 1988 Oct; 96(4):530-4. PubMed ID: 3172799
[TBL] [Abstract][Full Text] [Related]
35. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
Mastroroberto P; Chello M; Zofrea S; Marchese AR
Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
[TBL] [Abstract][Full Text] [Related]
36. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
37. Coronary artery bypass grafting after aprotinin: are we doing better?
Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
[TBL] [Abstract][Full Text] [Related]
38. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations.
Murkin JM; Lux J; Shannon NA; Guiraudon GM; Menkis AH; McKenzie FN; Novick RJ
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):554-61. PubMed ID: 7508071
[TBL] [Abstract][Full Text] [Related]
39. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
Havel M; Teufelsbauer H; Knöbl P; Dalmatiner R; Jaksch P; Zwölfer W; Müller M; Vukovich T
J Thorac Cardiovasc Surg; 1991 Jun; 101(6):968-72. PubMed ID: 1710009
[TBL] [Abstract][Full Text] [Related]
40. Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?
Englberger L; Kipfer B; Berdat PA; Nydegger UE; Carrel TP
Ann Thorac Surg; 2002 Jun; 73(6):1897-904. PubMed ID: 12078788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]